America’s overeating and lack of activity problem has put a record number of people in the overweight to morbidly obese category. GLp1 medications like Ozempic and Mounjaro are now getting considered for insurance plans. We’ll tell you why in the Market Intel segment as this insurance news could push up stocks like Eli Lilly even further.  Then Shelley Grandidge joins us to talk about Medicare and health insurance benefits, pricing, and deadlines--MASTERING MONEY is on the air!!!